subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: acute myocardial infarction


subject: CHEBI:68579

object_name: Acute Myocardial Infarction by ECG Finding

tested_intervention: yes


subject: MESH:C097921

object_name: bladder tumor

tested_intervention: unsure


subject: MESH:C097921

object_name: urinary bladder carcinoma


subject: MESH:C097921

object_name: urinary bladder cancer


subject: MESH:C097921

object_name: childhood bladder carcinoma


subject: MESH:C097921

object_name: Genitourinary Cancer


subject: CHEBI:50819

subject_name: Ferric oxide


subject: CHEBI:50819


subject: CHEBI:50819


subject: CHEBI:50819


subject: CHEBI:50819


subject: CHEBI:91450

subject_name: Sapanisertib

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:91450

object_name: Leptomeningeal Neoplasms


subject: UNII:B33561JJ61

subject_name: TELAGLENASTAT HYDROCHLORIDE

object_name: Stage IVB Lung Cancer AJCC v8


subject: UNII:B33561JJ61

object_name: Stage IVA Lung Cancer AJCC v8


subject: UNII:B33561JJ61

object_name: Non-small cell lung cancer recurrent


subject: UNII:B33561JJ61


subject: UNII:B33561JJ61


subject: UMLS:C5418246

subject_name: Telaglenastat Hydrochloride


subject: UMLS:C5418246


subject: UMLS:C5418246


subject: UMLS:C5418246


subject: UMLS:C5418246


subject: UMLS:C4045705

object_name: Childhood Neuroblastoma


subject: UMLS:C4045705

object_name: neuroblastoma


subject: UMLS:C4045705

object_name: Adult Rhabdomyosarcoma


subject: UMLS:C4045705

object_name: rhabdomyosarcoma


subject: UMLS:C4045705

object_name: Childhood Rhabdomyosarcoma


subject: UMLS:C4045705

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: UMLS:C4045705

object_name: pediatric osteosarcoma


subject: UMLS:C4045705

object_name: Osteosarcoma


subject: UMLS:C4045705

object_name: Ewing sarcoma


subject: UMLS:C4045705

object_name: Childhood Brain Neoplasm


subject: UMLS:C4045705

object_name: Childhood Solid Neoplasm


subject: UMLS:C4045705

object_name: pediatric lymphoma


subject: UMLS:C4045705

object_name: diffuse intrinsic pontine glioma


subject: UMLS:C1328240

subject_name: XYOTAX

object_name: Childhood Breast Carcinoma


subject: UMLS:C1328240

object_name: breast carcinoma


subject: UMLS:C1328240

object_name: breast cancer


subject: UMLS:C1328240

object_name: Carcinoma breast stage IV


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Locally Advanced Malignant Neoplasm


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:78320

subject_name: Lactic acid

object_name: post cardiac surgery


subject: UNII:T9FVH03HMZ

subject_name: Calaspargase pegol

object_name: Lymphoblastic T-cell lymphoma


subject: CHEBI:95165


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:177770

subject_name: Ganetespib

object_name: malignant soft tissue neoplasm


subject: CHEBI:177770

object_name: sarcoma


subject: CHEBI:61115

subject_name: EC 3.5.1.98 (histone deacetylase) inhibitor

object_name: Hodgkin Disease


subject: UMLS:C1512474

subject_name: Histone deacetylase inhibitor


subject: UMLS:C3537120

subject_name: Histone Deacetylase Inhibitor [EPC]


subject: UNII:7N8K34P2XH

subject_name: Detomidine

object_name: Postoperative shivering


subject: CHEBI:31528

subject_name: Ebastine

object_name: superficial epidermolytic ichthyosis


subject: CHEMBL.COMPOUND:CHEMBL2108905

subject_name: BCG VACCINE

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEMBL.COMPOUND:CHEMBL2108905

object_name: COPD, severe early onset


subject: UMLS:C0004886

subject_name: BCG Vaccine


subject: UMLS:C0004886


subject: UMLS:C0065828

subject_name: Measles-Mumps-Rubella Vaccine


subject: UMLS:C0065828


subject: UMLS:C0065828

object_name: chronic obstructive pulmonary disease


subject: CHEBI:6801

subject_name: Metformin

object_name: Pulmonary Hypertension, CTCAE


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: peritoneal carcinomatosis


subject: UMLS:C3896806


subject: UMLS:C1739076

object_name: Solid Neoplasm


subject: UMLS:C1739076


subject: UMLS:C1739076

object_name: urothelial carcinoma


subject: UMLS:C1739076

object_name: transitional cell carcinoma


subject: CHEBI:132922

object_name: Bedwetting


subject: CHEBI:132922

object_name: enuresis


subject: CHEBI:132922

object_name: Urinary incontinence of non-organic origin


subject: CHEBI:132922

object_name: Urinary incontinence


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:51209

subject_name: Pseudoephedrine


subject: CHEBI:51209


subject: CHEBI:51209


subject: CHEBI:51209


subject: UMLS:C4724859

subject_name: Geptanolimab

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:71219

subject_name: Pazopanib

object_name: atypical carcinoid tumor


subject: CHEBI:71219

object_name: Midgut Neuroendocrine Tumor G1


subject: CHEBI:71219

object_name: Metastatic well-differentiated neuroendocrine tumor


subject: CHEBI:71219

object_name: Foregut Neuroendocrine Tumor


subject: CHEBI:71219

object_name: Hindgut Neuroendocrine Tumor


subject: UMLS:C0540321

subject_name: Liberase

object_name: Frail elderly syndrome


subject: UMLS:C0540321

object_name: neurodegenerative disease


subject: CHEBI:26710

subject_name: Sodium chloride


subject: CHEBI:26710


subject: CHEBI:6129

subject_name: Ketorolac

object_name: Urinary Calculi


subject: PUBCHEM.COMPOUND:54214995

subject_name: Sacubitril


subject: UMLS:C4535511

subject_name: muscadine grape extract

object_name: Fatigue, CTCAE 5.0


subject: UMLS:C4535511

object_name: Fatigue


subject: UMLS:C4733271

subject_name: SB injection

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: Severe Acute Malnutrition


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: MESH:D003069

subject_name: Coffee

object_name: coronary artery disorder


subject: MESH:D003069

object_name: coronary atherosclerosis


subject: CHEBI:35469

subject_name: antidepressant

object_name: delirium


subject: CHEBI:35469

object_name: Delirium, CTCAE


subject: CHEBI:35469

object_name: age


subject: UMLS:C0003289

subject_name: Antidepressive Agents


subject: UMLS:C0003289


subject: UMLS:C0003289


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: Bone Resorption


subject: UMLS:C1530450

subject_name: AMG 162


subject: UMLS:C2349163

subject_name: Xenogeneic Tyrosinase DNA Vaccine

object_name: skin melanoma


subject: UMLS:C2349163

object_name: ocular melanoma


subject: UMLS:C2349163

object_name: uveal melanoma


subject: UMLS:C4331803

subject_name: MDM2-p53 Inhibitor APG-115

object_name: Childhood Neuroblastoma


subject: UMLS:C4331803

object_name: neuroblastoma


subject: UMLS:C4331803

object_name: Childhood Solid Neoplasm


subject: UMLS:C4331803

object_name: Adult Solid Neoplasm


subject: UMLS:C4331803

object_name: Solid Neoplasm


subject: UMLS:C4744685


subject: UMLS:C4744685


subject: UMLS:C4744685


subject: UMLS:C4744685


subject: UNII:LDJ89SS0YG

subject_name: Mosunetuzumab

object_name: Non-Hodgkin's lymphoma transformed recurrent


subject: UNII:LDJ89SS0YG

object_name: Follicular non-Hodgkin's lymphoma, large cell


subject: UNII:LDJ89SS0YG

object_name: Lymphoma, Large-Cell, Follicular


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: PUBCHEM.COMPOUND:6427057

subject_name: ivermectin

object_name: strongyloidiasis


subject: CHEBI:6078

subject_name: Ivermectin


subject: MESH:C519271

subject_name: bivatuzumab mertansine

object_name: head and neck neoplasm


subject: PUBCHEM.COMPOUND:15171724

subject_name: ANGIOTENSIN

object_name: traumatic encephalopathy


subject: PUBCHEM.COMPOUND:15171724

object_name: traumatic brain injury


subject: CHEBI:2719

subject_name: Angiotensin II


subject: CHEBI:2719


subject: UMLS:C0003018

subject_name: Angiotensins


subject: UMLS:C0003018


subject: DRUGBANK:DB17258

object_name: glioma


subject: DRUGBANK:DB17258

object_name: malignant glioma


subject: UMLS:C5238055

subject_name: Tengonermin

object_name: small cell lung carcinoma


subject: UMLS:C1143119

subject_name: Zafiride


subject: CHEBI:5103

subject_name: Flumazenil

object_name: Parkinson disease


subject: DRUGBANK:DB14235

subject_name: Bilberry

object_name: Memory observations


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: systemic lupus erythematosus arthritis


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:28159

subject_name: D-Asparagine

object_name: Graft Rejection


subject: CHEBI:28159

object_name: kidney disorder


subject: CHEBI:28159

object_name: impaired renal function disease


subject: CHEBI:62094


subject: CHEBI:62094


subject: CHEBI:62094


subject: CHEBI:135609

subject_name: Gusperimus


subject: CHEBI:135609


subject: CHEBI:135609


subject: UMLS:C5557417

subject_name: Enlonstobart

object_name: malignant mesothelioma


subject: UMLS:C5557417

object_name: cervical carcinoma


subject: UMLS:C5557417

object_name: adult lymphoma


subject: UMLS:C5557417

object_name: lymphoma


subject: UMLS:C5557417

object_name: pediatric lymphoma


subject: CHEBI:133023

subject_name: Lifitegrast

object_name: corneal disease


subject: CHEBI:135224

subject_name: Amitriptylinoxide

object_name: major depressive disorder


subject: CHEBI:7640

subject_name: Nortriptyline


subject: CHEBI:9738

subject_name: Trimipramine


subject: CHEBI:145499

subject_name: Donepezil

object_name: Mania, CTCAE


subject: CHEBI:145499

object_name: Mania


subject: CHEBI:145499

object_name: bipolar disorder


subject: UMLS:C5761796

subject_name: GVAX

object_name: plasma cell myeloma


subject: UMLS:C4525955

subject_name: Anti-CTLA4 Monoclonal Antibody BMS-986218

object_name: castration-resistant prostate carcinoma


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: small intestine cancer


subject: PUBCHEM.COMPOUND:92043599

object_name: small intestine carcinoma


subject: PUBCHEM.COMPOUND:92043599

object_name: myeloproliferative neoplasm


subject: CHEBI:189965

subject_name: Prosapogenin

object_name: arteriosclerosis disorder


subject: CHEBI:189965

object_name: atherosclerosis


subject: CHEBI:189965

object_name: Ischemic stroke


subject: DRUGBANK:DB01404

subject_name: Ginseng


subject: DRUGBANK:DB01404


subject: DRUGBANK:DB01404


subject: CHEBI:231678

subject_name: Evofosfamide

object_name: Advanced renal cell carcinoma


subject: CHEBI:231678

object_name: Plexosarcoma


subject: PUBCHEM.COMPOUND:89455219

subject_name: tirabrutinib

object_name: Refractory Central Nervous System Lymphoma


subject: CHEBI:51041

subject_name: Acamprosate

object_name: autism


subject: CHEBI:41423

subject_name: Celecoxib

object_name: acute respiratory distress syndrome


subject: CHEBI:41423

object_name: adult acute respiratory distress syndrome


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: acromegaly


subject: PUBCHEM.COMPOUND:155543961

object_name: Acral overgrowth


subject: PUBCHEM.COMPOUND:155543961

object_name: Cushing Disease


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin


subject: PUBCHEM.COMPOUND:11306691


subject: PUBCHEM.COMPOUND:11306691


subject: CHEBI:40237

subject_name: Sitagliptin


subject: CHEBI:40237


subject: CHEBI:40237


subject: PUBCHEM.COMPOUND:135423438

subject_name: Nintedanib

object_name: lymphangioleiomyomatosis


subject: PUBCHEM.COMPOUND:135423438

object_name: lung lymphangioleiomyomatosis


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:134716

subject_name: Brexpiprazole

object_name: alcohol abuse


subject: CHEBI:134716

object_name: alcohol dependence


subject: UNII:P0GVQ9A4S5

subject_name: Dostarlimab

object_name: bladder transitional cell carcinoma


subject: UNII:P0GVQ9A4S5

object_name: nonpapillary renal cell carcinoma


subject: UNII:P0GVQ9A4S5

object_name: clear cell renal carcinoma


subject: UNII:P0GVQ9A4S5

object_name: pancreatic ductal adenocarcinoma


subject: UNII:P0GVQ9A4S5

object_name: biliary tract cancer


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298

object_name: liver carcinoma


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:138650

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C3827145


subject: CHEBI:8988

object_name: cervical polyp


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:74947

subject_name: Thalidomide

object_name: Chronic radiation proctitis


subject: UniProtKB:P19726

subject_name: CAPSA_BPT7 Major capsid protein (sprot)

object_name: attention deficit hyperactivity disorder, inattentive type


subject: UniProtKB:P19726


subject: UNII:5Y869C2THE

object_name: Physical trauma


subject: UNII:5Y869C2THE

object_name: Injury


subject: UNII:5Y869C2THE

object_name: Trauma


subject: UNII:5Y869C2THE

object_name: Dysesthesia


subject: UNII:5Y869C2THE

object_name: neuralgia


subject: MESH:C469818


subject: MESH:C469818


subject: MESH:C469818


subject: MESH:C469818


subject: MESH:C469818


subject: UMLS:C0544377

subject_name: Insulin, injectable

object_name: type 1 diabetes mellitus 1


subject: UMLS:C0544377

object_name: type 1 diabetes mellitus


subject: UNII:717I541I2R

object_name: Solid Neoplasm


subject: UMLS:C2827528


subject: CHEBI:50815

subject_name: Norgestimate

object_name: osteoporosis


subject: CHEBI:50815

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:50815

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:50815

object_name: Osteoporosis, CTCAE 3.0


subject: UMLS:C5706555

subject_name: BRD4 Protein Degrader RNK05047

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5706555

object_name: diffuse large B-cell lymphoma


subject: PUBCHEM.COMPOUND:22573923

subject_name: Ipamorelin

object_name: Gastrointestinal dysmotility


subject: UMLS:C0757797

subject_name: ipamorelin


subject: UMLS:C1134664

object_name: Metastatic Breast Carcinoma


subject: CHEBI:7862

subject_name: Oxymetazoline

object_name: presbyopia


subject: CHEBI:150712

subject_name: Hyaluronic acid


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEBI:240107

subject_name: Bromfenac


subject: UMLS:C1706082

subject_name: Compound (substance)


subject: MESH:C478920

object_name: intermediate uveitis


subject: MESH:C478920

object_name: posterior uveitis


subject: CHEBI:16811

subject_name: Racemethionine

object_name: Malignant neoplasm of the central nervous system


subject: CHEBI:16811

object_name: brain cancer


subject: CHEBI:16811

object_name: brain neoplasm


subject: UMLS:C0034504

subject_name: racemethionine


subject: UMLS:C0034504


subject: UMLS:C0034504


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: Stage IV Colorectal Cancer AJCC v7


subject: CHEBI:22652

object_name: Stage IV Colorectal Cancer AJCC v6


subject: UNII:75FBL12IZ7

object_name: Childhood Soft Tissue Sarcoma


subject: UNII:75FBL12IZ7

object_name: Adult Soft Tissue Sarcoma


subject: UNII:75FBL12IZ7

object_name: sarcoma


subject: UNII:75FBL12IZ7

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UNII:75FBL12IZ7

object_name: soft tissue sarcoma


subject: UMLS:C2609439

subject_name: Medrol 4 MG Oral Tablet includes Medrol Dosepak

object_name: Contusions


subject: UMLS:C2609439

object_name: reported bruising (history)


subject: UMLS:C2609439

object_name: Bruising, CTCAE


subject: UMLS:C2609439

object_name: Post-Operative Pain


subject: UMLS:C2609439

object_name: Edema


subject: UMLS:C2609439

object_name: Postoperative Nausea


subject: UMLS:C2609439

object_name: Postoperative Complications


subject: UMLS:C2609439

object_name: Nasal congestion


subject: CHEBI:73272

subject_name: CANAGLIFLOZIN

object_name: Diabetes


subject: PUBCHEM.COMPOUND:74323022

subject_name: Canagliflozin


subject: CHEBI:9445

subject_name: Terazosin

object_name: Disorder of urinary stent


subject: CHEBI:9622

subject_name: Tolterodine


subject: CHEBI:28824

subject_name: stigmasterol

object_name: Dyslipidemia


subject: CHEBI:27693

subject_name: beta-Sitosterol


subject: UNII:4UQ3S81B25

subject_name: Piboserod

object_name: heart failure


subject: UNII:4UQ3S81B25

object_name: congestive heart failure


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: Severe Sepsis


subject: PUBCHEM.COMPOUND:2735

object_name: Sepsis


subject: PUBCHEM.COMPOUND:2735

object_name: Sepsis, CTCAE


subject: PUBCHEM.COMPOUND:2735

object_name: end organ damage


subject: PUBCHEM.COMPOUND:2735

object_name: multiple organ dysfunction syndrome


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C5963125

subject_name: Anti-GPC3/Anti-4-1BB Bispecific Antibody BGB-B2033

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C5963125

object_name: Metastatic hepatocellular carcinoma


subject: UMLS:C5963125

object_name: Advanced Hepatocellular Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095278

subject_name: LORIGERLIMAB

object_name: Prostate cancer recurrent


subject: CHEMBL.COMPOUND:CHEMBL5095278

object_name: castration-resistant prostate carcinoma


subject: UMLS:C4764259


subject: UMLS:C4764259


subject: CHEBI:7726

subject_name: octreotide

object_name: adenoma


subject: CHEBI:6801

subject_name: Metformin

object_name: pulmonary hypertension, primary, 1


subject: CHEBI:6801

object_name: idiopathic pulmonary arterial hypertension


subject: CHEBI:6801

object_name: pulmonary arterial hypertension


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: ischemia


subject: UNII:I031V2H011

object_name: Intracranial Atherosclerosis


subject: UNII:I031V2H011

object_name: atherosclerosis


subject: UNII:I031V2H011

object_name: cerebral infarction


subject: UNII:I031V2H011

object_name: brain disorder


subject: CHEBI:188074

object_name: hyperlipidemia


subject: CHEBI:188074

object_name: hyperlipoproteinemia


subject: CHEBI:188074

object_name: Hyperlipidemia, CTCAE


subject: CHEBI:188074

object_name: Serum lipids high (finding)


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: CHEBI:50122


subject: CHEBI:50122


subject: CHEBI:50122


subject: CHEBI:7553

subject_name: Niclosamide

object_name: colorectal carcinoma


subject: CHEBI:7553

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:60789

subject_name: bupivacaine hydrochloride hydrate

object_name: Transformed migraine


subject: CHEBI:149504

object_name: peripheral vascular disease


subject: CHEBI:149504

object_name: peripheral arterial disease


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6541


subject: CHEBI:8228

subject_name: Pioglitazone


subject: CHEBI:8228


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: Kidney transplant failure and rejection


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:167450

subject_name: Monomethyl fumarate


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:53498

subject_name: triacetylcellulose


subject: UMLS:C2962221

subject_name: TAC


subject: UMLS:C5705586

object_name: Dravet syndrome


subject: UMLS:C5705586

object_name: developmental and epileptic encephalopathy, 6A


subject: CHEBI:194548

subject_name: Racepinephrine

object_name: cardiac arrest


subject: CHEBI:194548

object_name: Cardiac Arrest, CTCAE


subject: UMLS:C5854568

subject_name: Oncolytic HSV-1 R130

object_name: endometrial cancer


subject: UMLS:C5854568

object_name: uterine corpus cancer


subject: UMLS:C5854568

object_name: endometrial carcinoma


subject: UMLS:C5854568

object_name: cervical cancer


subject: UMLS:C5854568

object_name: cervical carcinoma


subject: UMLS:C5854568

object_name: Advanced cancer


subject: CHEBI:176724

subject_name: Etiracetam

object_name: primary brain neoplasm


subject: CHEBI:176724

object_name: brain cancer


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: UNII:73HC18Y1LW


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:6437


subject: CHEBI:168243

subject_name: Valproic acid glucuronide

object_name: acute myeloid leukemia by FAB classification


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Metastatic Digestive System Carcinoma


subject: UNII:M89N0Q7EQR

object_name: Metastatic cholangiocarcinoma


subject: UNII:M89N0Q7EQR

object_name: Metastatic Esophageal Carcinoma


subject: UNII:M89N0Q7EQR

object_name: Malignant neoplasm of stomach stage IV


subject: UNII:M89N0Q7EQR

object_name: Stage IV Colorectal Cancer AJCC v7


subject: UNII:M89N0Q7EQR

object_name: Stage IV Esophageal Cancer AJCC v7


subject: UNII:M89N0Q7EQR

object_name: Stage IVA Colorectal Cancer AJCC v7


subject: UNII:M89N0Q7EQR

object_name: Stage IVB Colorectal Cancer AJCC v7


subject: UNII:M89N0Q7EQR

object_name: colorectal adenocarcinoma


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Metastatic Gastric Carcinoma


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: PR:000031444

subject_name: maestro heat-like repeat-containing protein family member 2B

object_name: autoimmune hepatitis


subject: UNII:G8RGG88B68

subject_name: Peginterferon alfa-2b

object_name: AIDS


subject: CHEBI:176724

object_name: Metastatic Adult Malignant Neoplasm in the Brain


subject: UNII:73HC18Y1LW


subject: CHEBI:6437


subject: MESH:C000627108

object_name: Ischemic stroke


subject: UMLS:C4705670


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: metastatic colorectal cancer


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:18050

subject_name: L-Glutamine


subject: PUBCHEM.COMPOUND:156501355

object_name: colorectal neoplasm


subject: PUBCHEM.COMPOUND:156501355

object_name: tumor suppressor gene on chromosome 11


subject: PUBCHEM.COMPOUND:156501355

object_name: colorectal cancer


subject: PUBCHEM.COMPOUND:156501355

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:230905

subject_name: Ribociclib


subject: CHEBI:230905


subject: CHEBI:230905

object_name: lung cancer


subject: UNII:PQX0D8J21J

subject_name: Cetuximab


subject: UMLS:C0879636

subject_name: IMC C225


subject: CHEBI:91414

subject_name: Adavosertib

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:91414

object_name: Pancreatic carcinoma non-resectable


subject: CHEBI:91414

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:91414


subject: UMLS:C4053677


subject: UMLS:C4053677


subject: UMLS:C4053677


subject: UMLS:C4053677


subject: UMLS:C5554939

subject_name: Becotatug

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:85974

subject_name: edoxaban tosylate hydrate

object_name: blood coagulation disease


subject: CHEBI:76842

object_name: alopecia totalis


subject: CHEBI:76842

object_name: alopecia universalis congenita


subject: CHEBI:76842

object_name: alopecia areata 1


subject: CHEBI:76842

object_name: alopecia universalis


subject: CHEBI:76842

object_name: alopecia areata


subject: CHEBI:76842

object_name: alopecia


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:7507

subject_name: Framycetin


subject: CHEBI:7507


subject: CHEBI:7507


subject: CHEBI:7507


subject: CHEBI:7507


subject: CHEBI:7507


subject: CHEMBL.COMPOUND:CHEMBL4298190

subject_name: OMIDUBICEL

object_name: Sickle cell-thalassemia disease


subject: UMLS:C2981846

object_name: estrogen-receptor positive breast cancer


subject: CHEBI:52763

object_name: meningeal tuberculosis


subject: CHEBI:73604

subject_name: Lys-Gly


subject: CHEBI:63611

subject_name: Moxifloxacin


subject: CHEBI:35341

subject_name: steroid


subject: UMLS:C5782153

subject_name: Steroid [EPC]


subject: MESH:C000593794

subject_name: GVAX vaccine

object_name: Childhood Neuroblastoma


subject: MESH:C000593794

object_name: neuroblastoma


subject: MESH:C000593794

object_name: Childhood Solid Neoplasm


subject: GTOPDB:11361

subject_name: brontictuzumab

object_name: adrenal cortex carcinoma


subject: GTOPDB:11361

object_name: adenoid cystic carcinoma


subject: UNII:UNY2TQA40E

subject_name: BRONTICTUZUMAB


subject: UNII:UNY2TQA40E


subject: UMLS:C3641170


subject: UMLS:C3641170


subject: CHEBI:8382

subject_name: Prednisone

object_name: lupus erythematosus


subject: CHEBI:8382

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:8382

object_name: Fatigue


subject: UNII:06H865SCMW

object_name: asthma


subject: UNII:HXH71NRQ5C

object_name: cardiac arrest


subject: UNII:HXH71NRQ5C

object_name: Cardiac Arrest, CTCAE


subject: UNII:HXH71NRQ5C

object_name: Hypoxic-Ischemic Encephalopathy


subject: UMLS:C5238480

object_name: medullary thyroid gland carcinoma


subject: UMLS:C5238480

object_name: familial medullary thyroid carcinoma


subject: UMLS:C5707633

subject_name: Lead Pb 203-VMT01

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: UMLS:C5855615

subject_name: Lead Pb 212-VMT01

object_name: metastatic melanoma


subject: UMLS:C5855615


subject: UMLS:C2240391

subject_name: Herbal medicine (product)

object_name: Shoulder pain


subject: UMLS:C2240391

object_name: Knee pain


subject: MESH:C078788

subject_name: ALVAC vaccine

object_name: Stage IC Ovarian Cancer AJCC v6 and v7


subject: MESH:C078788

object_name: stage IC ovarian epithelial cancer


subject: MESH:C078788

object_name: Stage IB Ovarian Cancer AJCC v6 and v7


subject: MESH:C078788

object_name: stage IB ovarian epithelial cancer


subject: MESH:C078788

object_name: Stage IA Ovarian Cancer


subject: MESH:C078788

object_name: Stage IA Fallopian Tube Cancer AJCC v8


subject: MESH:C078788

object_name: Stage IA Fallopian Tube Cancer AJCC v6 and v7


subject: MESH:C078788

object_name: Stage IB Fallopian Tube Cancer AJCC v6 and v7


subject: MESH:C078788

object_name: Stage IB Fallopian Tube Cancer AJCC v8


subject: MESH:C078788

object_name: Stage IC Fallopian Tube Cancer AJCC v6 and v7


subject: MESH:C078788

object_name: Stage IC Fallopian Tube Cancer AJCC v8


subject: MESH:C078788

object_name: stage IB primary peritoneal cavity cancer


subject: MESH:C078788

object_name: stage IA primary peritoneal cavity cancer


subject: MESH:C078788

object_name: stage IC primary peritoneal cavity cancer


subject: PUBCHEM.COMPOUND:146014907


subject: PUBCHEM.COMPOUND:146014907


subject: PUBCHEM.COMPOUND:146014907


subject: PUBCHEM.COMPOUND:146014907


subject: PUBCHEM.COMPOUND:146014907


subject: PUBCHEM.COMPOUND:146014907


subject: PUBCHEM.COMPOUND:146014907


subject: PUBCHEM.COMPOUND:146014907


subject: PUBCHEM.COMPOUND:146014907


subject: PUBCHEM.COMPOUND:146014907


subject: PUBCHEM.COMPOUND:146014907


subject: PUBCHEM.COMPOUND:146014907


subject: PUBCHEM.COMPOUND:146014907


subject: PUBCHEM.COMPOUND:146014907


subject: CHEMBL.COMPOUND:CHEMBL4594483


subject: CHEMBL.COMPOUND:CHEMBL4594483


subject: CHEMBL.COMPOUND:CHEMBL4594483


subject: CHEMBL.COMPOUND:CHEMBL4594483


subject: CHEMBL.COMPOUND:CHEMBL4594483


subject: CHEMBL.COMPOUND:CHEMBL4594483


subject: CHEMBL.COMPOUND:CHEMBL4594483


subject: CHEMBL.COMPOUND:CHEMBL4594483


subject: CHEMBL.COMPOUND:CHEMBL4594483


subject: CHEMBL.COMPOUND:CHEMBL4594483


subject: CHEMBL.COMPOUND:CHEMBL4594483


subject: CHEMBL.COMPOUND:CHEMBL4594483


subject: CHEMBL.COMPOUND:CHEMBL4594483


subject: CHEMBL.COMPOUND:CHEMBL4594483


subject: UMLS:C4329606

subject_name: CTAG1 Antibody


subject: UMLS:C4329606


subject: UMLS:C4329606


subject: UMLS:C4329606


subject: UMLS:C4329606


subject: UMLS:C4329606


subject: UMLS:C4329606


subject: UMLS:C4329606


subject: UMLS:C4329606


subject: UMLS:C4329606


subject: UMLS:C4329606


subject: UMLS:C4329606


subject: UMLS:C4329606


subject: UMLS:C4329606


subject: UniProtKB:P78358

subject_name: CTG1B_HUMAN Cancer/testis antigen 1 (sprot)


subject: UniProtKB:P78358


subject: UniProtKB:P78358


subject: UniProtKB:P78358


subject: UniProtKB:P78358


subject: UniProtKB:P78358


subject: UniProtKB:P78358


subject: UniProtKB:P78358


subject: UniProtKB:P78358


subject: UniProtKB:P78358


subject: UniProtKB:P78358


subject: UniProtKB:P78358


subject: UniProtKB:P78358


subject: UniProtKB:P78358


subject: UMLS:C2985191

object_name: stage IIIB ovarian epithelial cancer


subject: UMLS:C2985191

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2985191


subject: UMLS:C2985191


subject: UMLS:C2985191

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2985191

object_name: Ovarian cancer stage IV


subject: UMLS:C2985191


subject: UMLS:C2985191


subject: UMLS:C2985191


subject: UMLS:C2985191

object_name: Stage IIB Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2985191

object_name: stage IIB ovarian epithelial cancer


subject: UMLS:C2985191

object_name: Stage IIC Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2985191

object_name: stage IIA ovarian epithelial cancer


subject: UMLS:C2985191

object_name: Stage IIA Ovarian Cancer AJCC V6 and v7


subject: UMLS:C2985191

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: UMLS:C2985191

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: UMLS:C2985191

object_name: FIGO Stage IIIC Ovarian Cancer


subject: UMLS:C2985191

object_name: Stage IIIC Ovarian Cancer


subject: UMLS:C2985191

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2985191

object_name: FIGO Stage IIIA Ovarian Cancer


subject: UMLS:C2985191

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C2985191

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: UMLS:C2985191

object_name: Stage IA Fallopian Tube Cancer AJCC v8


subject: UMLS:C2985191

object_name: Stage IA Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C2985191

object_name: Stage IB Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C2985191

object_name: Stage IB Fallopian Tube Cancer AJCC v8


subject: UMLS:C2985191

object_name: Stage IC Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C2985191

object_name: Stage IC Fallopian Tube Cancer AJCC v8


subject: UMLS:C2985191

object_name: stage IIIB primary peritoneal cavity cancer


subject: UMLS:C2985191

object_name: Stage IIB Fallopian Tube Cancer AJCC v8


subject: UMLS:C2985191

object_name: Stage IIB Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C2985191

object_name: Stage IIC Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C2985191

object_name: Stage IIA Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C2985191

object_name: Stage IIA Fallopian Tube Cancer AJCC v8


subject: UMLS:C2985191

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: UMLS:C2985191

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: UMLS:C2985191

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: UMLS:C2985191

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: UMLS:C2985191

object_name: stage IB primary peritoneal cavity cancer


subject: UMLS:C2985191

object_name: stage IA primary peritoneal cavity cancer


subject: UMLS:C2985191

object_name: stage IV primary peritoneal cavity cancer


subject: UMLS:C2985191

object_name: stage IC primary peritoneal cavity cancer


subject: UMLS:C2985191

object_name: stage IIB primary peritoneal cavity cancer


subject: UMLS:C2985191

object_name: stage IIA primary peritoneal cavity cancer


subject: UMLS:C2985191

object_name: recurrent primary peritoneal cavity cancer


subject: UMLS:C2985191

object_name: stage IIIC primary peritoneal cavity cancer


subject: UMLS:C2985191

object_name: stage IIIA primary peritoneal cavity cancer


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Coxitis


subject: CHEBI:5847

subject_name: Raltitrexed

object_name: esophageal squamous cell carcinoma


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: lung cancer


subject: CHEBI:28939

object_name: lung neoplasm


subject: CHEBI:28939

object_name: lung carcinoma


subject: UNII:B71UA545DE

subject_name: artichoke leaf

object_name: inherited lipid metabolism disorder


subject: UNII:O43472U9X8

subject_name: Obinutuzumab

object_name: immunotactoid glomerulopathy


subject: UNII:O43472U9X8

object_name: non-amyloid fibrillary glomerulopathy


subject: UMLS:C0757679

object_name: breast neoplasm


subject: CHEBI:499361

subject_name: Aprepitant


subject: UMLS:C5959215

subject_name: Anti-nectin-4/MMAE Antibody-drug Conjugate CRB-701

object_name: cervical cancer


subject: UMLS:C5959215

object_name: cervical carcinoma


subject: CHEBI:15414

subject_name: Adomet

object_name: fibromyalgia


subject: CHEBI:67040

subject_name: Ademetionine


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: arthritis


subject: CHEBI:3160

object_name: Arthritis, CTCAE


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: Sicca Syndrome


subject: UMLS:C4055152

subject_name: Diclofenac Epolamine Patch

object_name: Childhood Breast Carcinoma


subject: UMLS:C4055152

object_name: breast carcinoma


subject: UMLS:C4055152

object_name: breast cancer


subject: CHEBI:8382

subject_name: Prednisone

object_name: COPD exacerbation


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: Dyspnea


subject: CHEBI:37941

object_name: Dyspnea, CTCAE


subject: CHEBI:37941

object_name: cardiovascular surgery result: dyspnea


subject: CHEBI:68558

subject_name: Ticagrelor


subject: CHEBI:68558


subject: CHEBI:68558


subject: UMLS:C0879372

subject_name: Recombinant Vaccinia-B7.1 Vaccine

object_name: skin melanoma


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: Metastatic Carcinoma to the Uterine Cervix


subject: CHEBI:49140

object_name: adult lymphoma


subject: CHEBI:49140

object_name: lymphoma


subject: CHEBI:49140

object_name: pediatric lymphoma


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:61115

subject_name: EC 3.5.1.98 (histone deacetylase) inhibitor

object_name: essential thrombocythemia


subject: CHEBI:61115

object_name: acquired polycythemia vera


subject: UMLS:C1512474

subject_name: Histone deacetylase inhibitor


subject: UMLS:C1512474


subject: UMLS:C3537120

subject_name: Histone Deacetylase Inhibitor [EPC]


subject: UMLS:C3537120


subject: UMLS:C4704764


subject: UMLS:C4704764


subject: CHEMBL.COMPOUND:CHEMBL2108446

subject_name: GUAR GUM

object_name: abdominal obesity-metabolic syndrome


subject: CHEMBL.COMPOUND:CHEMBL2108446

object_name: metabolic syndrome X


subject: CHEMBL.COMPOUND:CHEMBL2108446

object_name: Albuminuria


subject: CHEBI:76016

subject_name: Vortioxetine

object_name: Effects of radiation


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: cancer of unknown primary site


subject: UMLS:C4733594

object_name: Cardiopulmonary Function


subject: CHEBI:45716

subject_name: Vorinostat

object_name: Stage III Rectal Cancer AJCC v6


subject: CHEBI:45716

object_name: Stage III Rectal Cancer AJCC v7


subject: CHEBI:45716

object_name: Stage III Rectal Cancer AJCC v8


subject: CHEBI:45716

object_name: Stage III Colon Cancer AJCC v7


subject: CHEBI:45716

object_name: Stage III Colon Cancer AJCC v8


subject: CHEBI:45716

object_name: Stage III Colon Cancer


subject: UMLS:C1879711

subject_name: AMG 102

object_name: esophageal cancer


subject: UNII:6A901E312A

subject_name: Panitumumab

object_name: gastric cancer


subject: UMLS:C2348288

subject_name: Dietary Zinc

object_name: Tinnitus


subject: UMLS:C2348288

object_name: Tinnitus, CTCAE 5.0


subject: UMLS:C2348288

object_name: Tinnitus, CTCAE 3.0


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:29105


subject: CHEBI:29105


subject: CHEBI:27363

subject_name: Zinc


subject: CHEBI:27363


subject: CHEBI:27363


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3541396


subject: UMLS:C3541396


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: UMLS:C3714650


subject: UMLS:C3714650


subject: UMLS:C2348261

subject_name: Dietary Chromium

object_name: Finding of blood glucose level


subject: CHEBI:28073

subject_name: Chromium


subject: CHEBI:49544

subject_name: Chromic cation


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: Arrhythmia


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Recurrent tumor


subject: PR:000001379


subject: PR:000001151

subject_name: Toll-like receptor 1

object_name: Childhood Solid Neoplasm


subject: PR:000001151

object_name: Adult Solid Neoplasm


subject: PR:000001151

object_name: Solid Neoplasm


subject: PR:000001151

object_name: Disseminated Malignant Neoplasm


subject: PR:000001151

object_name: Embolism, Tumor


subject: PR:000001151

object_name: Neoplasm Metastasis


subject: PR:000001151


subject: CHEBI:114785

subject_name: Erlotinib

object_name: Stage IIA Pancreatic Cancer AJCC v8


subject: CHEBI:114785

object_name: Stage IIA Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:114785

object_name: stage IIA pancreatic cancer


subject: CHEBI:114785

object_name: Stage IA Pancreatic Cancer AJCC v8


subject: CHEBI:114785

object_name: Stage IA Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:114785

object_name: stage IB pancreatic cancer


subject: CHEBI:114785

object_name: Stage IB Pancreatic Cancer AJCC v8


subject: CHEBI:114785

object_name: Stage IB Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:114785

object_name: stage IIB pancreatic cancer


subject: CHEBI:114785

object_name: Stage IIB Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:114785

object_name: Stage IIB Pancreatic Cancer AJCC v8


subject: CHEBI:114785

object_name: pancreatic intraductal papillary-mucinous neoplasm


subject: CHEBI:75832

subject_name: ferrous sulfate

object_name: Anemia of pregnancy


subject: CHEBI:135948

subject_name: Amifampridine

object_name: spinal muscular atrophy, type III


subject: CHEBI:167309

subject_name: Methadone

object_name: Chronic nonmalignant pain


subject: UMLS:C1875730

subject_name: RINGER'S

object_name: heart failure


subject: UMLS:C1875730

object_name: Heart Failure, CTCAE


subject: CHEBI:75958

subject_name: solution


subject: CHEBI:75958


subject: UMLS:C0037633

subject_name: Solutions


subject: UMLS:C0037633


subject: CHEBI:63610

subject_name: Misoprostol

object_name: Bleeding ulcer


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Mesothelioma


subject: CHEBI:28939

object_name: mesothelial neoplasm


subject: CHEBI:28939

object_name: malignant mesothelioma


subject: CHEBI:28939

object_name: small cell lung carcinoma


subject: CHEBI:28939

object_name: non-small cell lung carcinoma


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: Waldenstrom macroglobulinemia


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: UMLS:C5222462

subject_name: Liraglutide Injection

object_name: obesity due to congenital leptin deficiency


subject: UMLS:C5222462

object_name: obesity due to leptin receptor gene deficiency


subject: UMLS:C5222462

object_name: morbid obesity


subject: UMLS:C5222462

object_name: bariatric surgery candidate


subject: UMLS:C5222462

object_name: Weight loss


subject: UMLS:C5222462

object_name: Weight Loss, CTCAE


subject: PUBCHEM.COMPOUND:66586232

object_name: Catheter related infection


subject: PUBCHEM.COMPOUND:66586232

object_name: infection due to indwelling urinary catheter


subject: CHEBI:3614

subject_name: Chlorhexidine


subject: CHEBI:3614


subject: CHEBI:7565

subject_name: Nifedipine

object_name: Raynaud disease


subject: CHEBI:7565

object_name: cardiovascular disorder


subject: CHEBI:7565

object_name: aneurysm


subject: CHEBI:7565

object_name: heart disorder


subject: UNII:4QPV12Y60L

subject_name: Pimonidazole Hydrochloride

object_name: pancreatic neoplasm


subject: UNII:4QPV12Y60L

object_name: exocrine pancreatic carcinoma


subject: UNII:4QPV12Y60L

object_name: malignant pancreatic neoplasm


subject: UMLS:C1519087


subject: UMLS:C1519087


subject: UMLS:C1519087


subject: CHEBI:51348

subject_name: tetraphene

object_name: melanoma, cutaneous malignant, susceptibility to, 2


subject: CHEBI:51348

object_name: skin melanoma


subject: CHEBI:29022

subject_name: N-benzyladenine


subject: CHEBI:29022


subject: PUBCHEM.COMPOUND:53477793


subject: PUBCHEM.COMPOUND:53477793


subject: CHEBI:32594

subject_name: barium atom


subject: CHEBI:32594


subject: CHEBI:3087

subject_name: Betulinic Acid


subject: CHEBI:3087


subject: CHEBI:37136


subject: CHEBI:37136


subject: DRUGBANK:DB12481

subject_name: Barium


subject: DRUGBANK:DB12481


subject: UMLS:C4289970

subject_name: Anti-PD1 Monoclonal Antibody

object_name: metastatic melanoma


subject: UMLS:C5960606

subject_name: Treg Inhibitor GIM-531

object_name: Childhood Solid Neoplasm


subject: UMLS:C5960606

object_name: Adult Solid Neoplasm


subject: UMLS:C5960606

object_name: Solid Neoplasm


subject: UMLS:C5960606


subject: GTOPDB:12517

subject_name: tafolecimab

object_name: lung cancer


subject: GTOPDB:12517

object_name: lung neoplasm


subject: GTOPDB:12517

object_name: lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594554

subject_name: TAFOLECIMAB


subject: CHEMBL.COMPOUND:CHEMBL4594554


subject: CHEMBL.COMPOUND:CHEMBL4594554


subject: UMLS:C5419329

subject_name: Tafolecimab


subject: UMLS:C5419329


subject: UMLS:C5419329


subject: DRUGBANK:DB13959

subject_name: Medium-chain triglycerides

object_name: Critical Illness


subject: PR:000010231

subject_name: malonyl-CoA-acyl carrier protein transacylase, mitochondrial


subject: PR:000022561

subject_name: malonyl CoA-acyl carrier protein transacylase


subject: PR:000023036


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: PUBCHEM.COMPOUND:124723

object_name: Acetaminophen overdose


subject: PUBCHEM.COMPOUND:124723

object_name: paracetamol poisoning


subject: PUBCHEM.COMPOUND:124723

object_name: overdose


subject: PUBCHEM.COMPOUND:124723

object_name: drug-induced liver injury


subject: PUBCHEM.COMPOUND:124723

object_name: liver failure


subject: CHEBI:233593

subject_name: Flumatinib

object_name: acute leukemia


subject: CHEBI:17549

subject_name: Aminolevulinic acid

object_name: mitral valve disorder


subject: CHEBI:17549

object_name: Mitral Valve Disease, CTCAE


subject: CHEBI:17549

object_name: aortic valve disorder


subject: CHEBI:17549

object_name: aortic valve disease 1


subject: CHEBI:17549

object_name: Aortic Valve Disease, CTCAE


subject: CHEBI:234147

subject_name: sodium ferrous citrate


subject: CHEBI:234147


subject: CHEBI:234147


subject: CHEBI:234147


subject: CHEBI:234147


subject: UMLS:C5227827


subject: UMLS:C5227827


subject: UMLS:C5227827


subject: UMLS:C5227827


subject: UMLS:C5227827


subject: UMLS:C0723176

subject_name: SFC (Brand Name)


subject: UMLS:C0723176


subject: UMLS:C0723176


subject: UMLS:C0723176


subject: UMLS:C0723176


subject: CHEBI:49200

subject_name: EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor

object_name: acute pancreatitis


subject: UMLS:C0358591

subject_name: Proton Pump Inhibitors


subject: UMLS:C3536754

subject_name: Proton Pump Inhibitor [EPC]


subject: CHEBI:8988

object_name: carcinoma


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:167204

subject_name: Mosapride

object_name: Postoperative ileus


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: periodontitis, chronic, adult


subject: CHEBI:60648

object_name: chronic periodontitis


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: CHEBI:6931

subject_name: Midazolam

object_name: Myocardial injury


subject: CHEBI:9130

subject_name: Sevoflurane


subject: UMLS:C5417990

subject_name: Multi-epitope HER2 Peptide Vaccine TPIV100

object_name: Stage III Breast Cancer AJCC v7


subject: UMLS:C5417990

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: UMLS:C5417990

object_name: Stage IIIB Breast Carcinoma


subject: UMLS:C5417990

object_name: Stage IIIA Breast Carcinoma


subject: UMLS:C5417990

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UMLS:C5417990

object_name: Stage IIA Breast Carcinoma


subject: UMLS:C5417990

object_name: Stage IIB Breast Carcinoma


subject: UMLS:C5417990

object_name: breast adenocarcinoma


subject: PUBCHEM.COMPOUND:21982856

subject_name: Urea urea

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:21982856

object_name: prostate cancer


subject: CHEBI:36934

subject_name: nitrogen-15 atom


subject: CHEBI:36934


subject: CHEBI:63005

subject_name: Sodium nitrate

object_name: Angina pectoris


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: progressive supranuclear palsy


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: UMLS:C5943333

object_name: acute coronary syndrome


subject: UMLS:C5943333

object_name: myocardial infarction


subject: UMLS:C5943333

object_name: Myocardial Infarction, CTCAE


subject: UMLS:C5943333

object_name: Myocardial Infarction by ECG Finding


subject: UMLS:C5943333

object_name: Blood Clot


subject: UMLS:C5943333

object_name: thrombosis


subject: UMLS:C5943333

object_name: Thrombosis of blood vessel


subject: UMLS:C3177552

subject_name: Revacept


subject: UMLS:C3177552


subject: UMLS:C3177552


subject: UMLS:C3177552


subject: UMLS:C3177552


subject: UMLS:C3177552


subject: UMLS:C3177552


subject: CHEBI:63660

object_name: liver carcinoma


subject: CHEBI:38721

subject_name: Methamidophos

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:56841626

subject_name: Betalains

object_name: outcomes general quality of life


subject: PUBCHEM.COMPOUND:56841626

object_name: Perceived quality of life


subject: PUBCHEM.COMPOUND:56841626

object_name: Good quality of life


subject: PUBCHEM.COMPOUND:56841626

object_name: Vascular Stiffness


subject: PUBCHEM.COMPOUND:56841626

object_name: Vasodilation disorder


subject: CHEBI:22861

subject_name: betalain


subject: CHEBI:22861


subject: CHEBI:22861


subject: CHEBI:22861


subject: CHEBI:22861


subject: UMLS:C5854572

subject_name: ALDH2 Activator FP-045

object_name: Fanconi anemia


subject: UMLS:C5854572

object_name: Fanconi anemia complementation group A


subject: UNII:7KKS9R192F

subject_name: Gimatecan

object_name: pancreatic neoplasm


subject: UNII:7KKS9R192F

object_name: exocrine pancreatic carcinoma


subject: UNII:7KKS9R192F

object_name: malignant pancreatic neoplasm


subject: UMLS:C2698134

subject_name: demcizumab

object_name: colorectal cancer


subject: UMLS:C2698134

object_name: colorectal carcinoma


subject: UMLS:C2698134

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:94534

subject_name: olanzapine

object_name: Nausea and vomiting


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Mechanical ventilation finding


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:6129

subject_name: Ketorolac


subject: PUBCHEM.COMPOUND:134506

subject_name: Dehydroandrosterone

object_name: Anorexia


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:85252

subject_name: synaptamide


subject: CHEBI:89608

subject_name: Cervonoyl ethanolamide


subject: PUBCHEM.COMPOUND:21628493

subject_name: ESTROGEN


subject: CHEBI:50114

subject_name: estrogen


subject: CHEBI:4903

subject_name: Ethinylestradiol


subject: UMLS:C2936882

subject_name: Estrogen [EPC]


subject: UMLS:C0033307

subject_name: Progestational Hormones, Synthetic


subject: CHEBI:59826

subject_name: progestin


subject: UMLS:C3536710

subject_name: Progestin [EPC]


subject: UMLS:C0205992

subject_name: vancomycin hydrochloride

object_name: Infection


subject: UMLS:C0205992

object_name: infectious disease


subject: UMLS:C0205992

object_name: Adverse Event Associated with Infection


subject: RXCUI:718834

subject_name: Coartem

object_name: Uncomplicated malaria


subject: CHEBI:4670

subject_name: Dobutamine

object_name: Neck Carcinoma


subject: CHEBI:4670

object_name: head and neck neoplasm


subject: CHEBI:4670

object_name: head and neck cancer


subject: CHEBI:4670

object_name: Hypotension, CTCAE


subject: CHEBI:4670

object_name: lip and oral cavity carcinoma


subject: CHEBI:4670

object_name: oral cavity cancer


subject: CHEBI:135507

subject_name: Dopexamine


subject: CHEBI:135507


subject: CHEBI:135507


subject: CHEBI:135507

object_name: hypotension


subject: CHEBI:135507


subject: CHEBI:135507


subject: CHEBI:135507


subject: CHEBI:28918

subject_name: Epinephrine


subject: CHEBI:28918


subject: CHEBI:28918


subject: CHEBI:28918


subject: CHEBI:28918


subject: CHEBI:33569

subject_name: noradrenaline


subject: CHEBI:33569


subject: CHEBI:18357

subject_name: Norepinephrine


subject: CHEBI:18357


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Abnormal renal physiology


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:201431

subject_name: Cyclosporin H


subject: CHEBI:4031

subject_name: Cyclosporine


subject: HMDB:HMDB0001349

subject_name: Selenium

object_name: end stage renal failure


subject: HMDB:HMDB0001349

object_name: Chronic uremia


subject: UMLS:C0521939

subject_name: Selenium supplement


subject: UMLS:C0521939


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: chronic pancreatitis


subject: PUBCHEM.COMPOUND:2735

object_name: hereditary chronic pancreatitis


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL


subject: UNII:1C6V77QF41


subject: UNII:43K1W2T1M6

subject_name: Interferon alfa-2b

object_name: chronic hepatitis C virus infection


subject: UMLS:C0021735

subject_name: Viraferon


subject: UMLS:C5552625

subject_name: Interferon alfa-2b [EPC]


subject: UMLS:C4307370


subject: CHEBI:42567

subject_name: Fisetin

object_name: Femoroacetabular impingement


subject: CHEBI:17026

subject_name: Progesterone

object_name: Twin dichorionic diamniotic placenta


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: UMLS:C0599934

subject_name: Vaccines, Peptide

object_name: neoplasm


subject: UMLS:C0599934

object_name: plasma cell myeloma


subject: UMLS:C0006611

subject_name: Mucin-1 Antigen


subject: UMLS:C0006611


subject: PR:000001890


subject: PR:000001890


subject: CHEBI:15342

subject_name: acenaphthoquinone

object_name: hyperinsulinism


subject: CHEBI:15342

object_name: Hyperinsulinemia


subject: CHEBI:15342

object_name: type 2 diabetes mellitus


subject: CHEBI:15342

object_name: Insulin resistance


subject: CHEBI:15342

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:15342

object_name: obesity


subject: CHEBI:15342

object_name: Obesity, CTCAE


subject: CHEBI:15342

object_name: Prediabetes


subject: CHEBI:15342

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:73788

subject_name: Ala-Gln


subject: CHEBI:73788


subject: CHEBI:73788


subject: CHEBI:73788


subject: CHEBI:73788


subject: CHEBI:73788


subject: CHEBI:73788


subject: CHEBI:73788


subject: CHEMBL.COMPOUND:CHEMBL5314341

subject_name: GLUCAGON


subject: CHEBI:5391

subject_name: Glucagon


subject: CHEBI:37845

subject_name: growth hormone


subject: CHEBI:37845


subject: CHEBI:37845


subject: PUBCHEM.COMPOUND:170907453

subject_name: Growth hormone


subject: PUBCHEM.COMPOUND:170907453


subject: PUBCHEM.COMPOUND:170907453


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin


subject: UNII:NQX9KB6PCL


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C0169964


subject: UMLS:C0037663

subject_name: Growth Hormone


subject: UMLS:C0037663


subject: UMLS:C0037663


subject: PR:000007968

subject_name: somatotropin


subject: PR:000007968


subject: PR:000007968


subject: UMLS:C4721874

subject_name: human insulin


subject: UMLS:C4721874


subject: UMLS:C4721874


subject: UMLS:C0306371

subject_name: Humulin R


subject: PUBCHEM.COMPOUND:6917964

subject_name: OCTREOTIDE ACETATE


subject: PUBCHEM.COMPOUND:6917964


subject: CHEBI:7726

subject_name: octreotide


subject: CHEBI:7726


subject: UMLS:C3273553

subject_name: Sam68 Modulator CWP232291


subject: UMLS:C0017007

subject_name: Gamma globulin

object_name: polymyositis


subject: UMLS:C0017007

object_name: adult dermatomyositis


subject: UMLS:C0017007

object_name: dermatomyositis


subject: UMLS:C0017007

object_name: inclusion body myositis


subject: CHEBI:131166

subject_name: Berzosertib

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:131166

object_name: Metastatic Fallopian Tube Carcinoma


subject: CHEBI:131166

object_name: Metastatic Primary Peritoneal Carcinoma


subject: CHEBI:131166

object_name: Stage IV Ovarian Carcinoma


subject: CHEBI:131166

object_name: Platinum-Sensitive Ovarian Carcinoma


subject: CHEBI:131166

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: CHEBI:131166

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:131166

object_name: ovarian endometrial cancer


subject: CHEBI:131166

object_name: high grade ovarian serous adenocarcinoma


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Venous stenosis


subject: UMLS:C2703172

subject_name: CF102 compound


subject: UMLS:C1130504

object_name: Dysmenorrhea, CTCAE


subject: UMLS:C1130504

object_name: Dysmenorrhea


subject: CHEBI:32016

subject_name: Pirfenidone

object_name: uterine fibroid


subject: CHEBI:32016

object_name: leiomyoma


subject: CHEBI:125628

subject_name: Alisertib

object_name: gastroesophageal adenocarcinoma


subject: CHEBI:125628

object_name: non-small cell lung carcinoma


subject: UMLS:C1250042

subject_name: oxytocin nasal spray

object_name: sarcopenia


subject: UMLS:C1250042

object_name: Sarcopenic obesity


subject: UMLS:C1250042

object_name: Sedentary lifestyle


subject: CHEBI:2950

subject_name: Azelastine

object_name: Dust mite allergy


subject: CHEBI:5134

subject_name: Fluticasone


subject: PUBCHEM.COMPOUND:23667621

subject_name: DEXAMETHASONE SODIUM PHOSPHATE

object_name: peripheral vascular disease


subject: PUBCHEM.COMPOUND:23667621

object_name: peripheral arterial disease


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: PUBCHEM.COMPOUND:20473337

subject_name: Diethylcarbamazine

object_name: loiasis


subject: PUBCHEM.COMPOUND:6427057

subject_name: ivermectin


subject: CHEBI:6078

subject_name: Ivermectin


subject: CHEBI:5931

subject_name: insulin human

object_name: Insulin-requiring type 2 diabetes mellitus


subject: UMLS:C0876064

subject_name: Lantus


subject: CHEBI:60783

subject_name: nucleoside analogue

object_name: hepatitis B


subject: CHEBI:60783

object_name: liver carcinoma


subject: CHEBI:60783

object_name: Klatskin Tumor


subject: CHEMBL.COMPOUND:CHEMBL2108494

subject_name: INTERFERON


subject: CHEMBL.COMPOUND:CHEMBL2108494


subject: UMLS:C3652465

subject_name: Interferon


subject: UMLS:C3652465


subject: UMLS:C0021747

subject_name: Interferons


subject: UMLS:C0021747


subject: UMLS:C0733470

subject_name: human leukocyte interferon


subject: UMLS:C0733470


subject: UMLS:C3491977

object_name: chronic hepatitis C virus infection


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: coronary microvascular disorder


subject: UMLS:C1099192


subject: CHEBI:4806

subject_name: Epigallocatechin gallate

object_name: breast neoplasm


subject: CHEBI:4806

object_name: dermatitis


subject: CHEBI:4806

object_name: Dermatitis


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: Gastrointestinal hemorrhage


subject: GTOPDB:13709

subject_name: olpasiran

object_name: Hepatic impairment


subject: DRUGBANK:DB19001

subject_name: Olpasiran


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: anosmia


subject: UMLS:C3714501

object_name: Parosmia


subject: UMLS:C3714501

object_name: Hyposmia


subject: UMLS:C3714501

object_name: Anosmia, CTCAE


subject: CHEBI:5931


subject: CHEBI:5931


subject: CHEBI:5931


subject: CHEBI:5931


subject: CHEBI:135935

subject_name: Tapentadol

object_name: sciatica


subject: DRUGBANK:DB19282

subject_name: Lacticaseibacillus rhamnosus

object_name: anxiety


subject: DRUGBANK:DB19282

object_name: anxiety disorder


subject: DRUGBANK:DB19282

object_name: Anxiety symptoms


subject: DRUGBANK:DB19282

object_name: Anxiety, CTCAE 3.0


subject: DRUGBANK:DB19282

object_name: Anxiety, CTCAE 5.0


subject: DRUGBANK:DB19282

object_name: Abdominal pain


subject: DRUGBANK:DB19282

object_name: Abdominal Pain, CTCAE


subject: PUBCHEM.COMPOUND:3298

subject_name: Eicosapentaenoic acid ethyl ester

object_name: schizophrenia


subject: PUBCHEM.COMPOUND:3298

object_name: psychosis


subject: PUBCHEM.COMPOUND:3298

object_name: schizophreniform disorder


subject: PUBCHEM.COMPOUND:3298

object_name: schizoaffective disorder


subject: PUBCHEM.COMPOUND:3298

object_name: schizophrenia 18


subject: UMLS:C1565135

subject_name: Ethyl-EPA


subject: UMLS:C1565135


subject: UMLS:C1565135


subject: UMLS:C1565135


subject: UMLS:C1565135


subject: CHEBI:84883

subject_name: Icosapent ethyl


subject: CHEBI:84883


subject: CHEBI:84883


subject: CHEBI:84883


subject: CHEBI:84883


subject: CHEBI:37144

subject_name: epichlorohydrin


subject: CHEBI:37144


subject: CHEBI:37144


subject: CHEBI:37144


subject: CHEBI:37144


subject: CHEBI:28364

subject_name: Icosapent


subject: CHEBI:28364


subject: PR:000016352

subject_name: metalloproteinase inhibitor 1


subject: PR:000016352


subject: PR:000016352


subject: PR:000016352


subject: PR:000016352


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: CHEBI:18145


subject: CHEBI:18145


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: human coronavirus pneumonia


subject: CHEBI:8871

subject_name: Risperidone

object_name: Addiction


subject: CHEBI:10119

subject_name: Ziprasidone


subject: CHEBI:119915

subject_name: Fentanyl

object_name: portal hypertension


subject: CHEBI:119915

object_name: Portal Hypertension, CTCAE


subject: CHEBI:133021

subject_name: Venetoclax

object_name: metastatic prostate carcinoma


subject: CHEBI:133021

object_name: Stage IVB Prostate Cancer AJCC v8


subject: CHEBI:133021

object_name: Stage IVA Prostate Cancer AJCC v8


subject: CHEBI:133021

object_name: Prostate Carcinoma Metastatic in the Bone


subject: CHEBI:133021

object_name: Prostate Carcinoma Metastatic in the Soft Tissue


subject: CHEBI:133021

object_name: Castration Levels of Testosterone


subject: CHEBI:133021

object_name: PSA Progression


subject: UNII:JQ11LH711M

subject_name: Bindarit

object_name: diabetic kidney disease


subject: CHEBI:6801

subject_name: Metformin

object_name: age-related macular degeneration


subject: CHEBI:6801

object_name: Geographic atrophy


subject: CHEBI:6801

object_name: age related macular degeneration 1


subject: MESH:D008506

subject_name: Medical Waste

object_name: Nodule of lung


subject: MESH:D008506

object_name: lung cancer


subject: MESH:D008506

object_name: lung neoplasm


subject: MESH:D008506

object_name: lung carcinoma


subject: CHEBI:7772

subject_name: omeprazole

object_name: cysticercosis


subject: CHEBI:7772

object_name: Neurocysticercosis


subject: CHEBI:7772

object_name: Central Nervous System Cysticercosis


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: CHEBI:77260


subject: PUBCHEM.COMPOUND:9867822

subject_name: Lestaurtinib

object_name: Childhood Neuroblastoma


subject: PUBCHEM.COMPOUND:9867822

object_name: neuroblastoma


subject: CHEBI:91471


subject: CHEBI:91471


subject: PUBCHEM.COMPOUND:6397238

object_name: Burn injury


subject: CHEBI:60871


subject: CHEBI:68573

subject_name: indacaterol maleate

object_name: obstructive lung disease


subject: CHEBI:139072

object_name: Distress


subject: CHEBI:139072

object_name: Emotional Distress


subject: CHEBI:139072

object_name: Loss, Grief, and Bereavement


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:8614


subject: CHEBI:8614


subject: UMLS:C4305774

object_name: Congenital IGHD


subject: UMLS:C4305774

object_name: Reduced circulating growth hormone concentration


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: neoplasm


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:16302

object_name: Maternal morbidity


subject: UNII:81G40H8B0T

subject_name: VITAMIN A


subject: UMLS:C3714656

subject_name: Vitamin A Drug Class


subject: CHEBI:12777

subject_name: Vitamin A


subject: UMLS:C2825076

subject_name: Vitamin A [EPC]


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: Complication of hemodialysis


subject: CHEBI:91418

subject_name: Foretinib

object_name: head and neck neoplasm


subject: CHEBI:45783

subject_name: Imatinib

object_name: gastric adenocarcinoma


subject: CHEBI:46058

subject_name: TAXOTERE


subject: UMLS:C0037657

subject_name: Somatomedins

object_name: Myelodysplasia


subject: UMLS:C0037657

object_name: chronic myelomonocytic leukemia


subject: UMLS:C0037657

object_name: myelodysplastic syndrome with excess blasts


subject: UniProtKB:P47802

subject_name: MTX1_MOUSE Metaxin-1 (sprot)


subject: UniProtKB:P47802


subject: UniProtKB:P47802


subject: PR:000010755


subject: PR:000010755


subject: PR:000010755


subject: CHEBI:15365

subject_name: Aspirin

object_name: pathologic hemodilution


subject: PUBCHEM.COMPOUND:27991

subject_name: dAVP


subject: PUBCHEM.COMPOUND:16051933

subject_name: DESMOPRESSIN


subject: UNII:YZS3R7LP44

subject_name: Palonosetron

object_name: malignant glioma


subject: CHEBI:2567

subject_name: Alendronic acid

object_name: metabolic bone disorder


subject: CHEBI:63630

subject_name: Tolcapone

object_name: Childhood Neuroblastoma


subject: CHEBI:63630

object_name: neuroblastoma


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: Morbidly adherent placenta (disorder)


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UNII:MWI54OUA12

subject_name: Vercirnon

object_name: celiac disease


subject: MESH:C583420


subject: PUBCHEM.COMPOUND:3222

object_name: IgA Nephropathy


subject: CHEBI:4784

subject_name: Enalapril


subject: CHEBI:74224

object_name: Alzheimer disease


subject: CHEBI:27514

subject_name: genistin


subject: CHEBI:28088

subject_name: Genistein


subject: CHEBI:32551

object_name: mucositis


subject: CHEBI:32551

object_name: Oral Complication of Radiation Therapy


subject: CHEBI:32551

object_name: Oral Complication of Chemotherapy


subject: CHEBI:32551

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:32551

object_name: Mucoepidermoid carcinoma of the oral cavity recurrent


subject: CHEBI:32551

object_name: Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:32551

object_name: Stage II Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:32551

object_name: Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:32551

object_name: Stage I Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:32551

object_name: Mucoepidermoid carcinoma of the oral cavity stage III


subject: CHEBI:32551

object_name: Mucoepidermoid carcinoma of the oral cavity stage II


subject: CHEBI:32551

object_name: Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


subject: CHEBI:32551

object_name: Mucoepidermoid carcinoma of the oral cavity stage I


subject: CHEBI:32551

object_name: Recurrent Salivary Gland Cancer


subject: CHEBI:32551

object_name: Adenoid cystic carcinoma of the oral cavity recurrent


subject: CHEBI:32551

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: CHEBI:32551

object_name: Adenoid cystic carcinoma of the oral cavity stage III


subject: CHEBI:32551

object_name: Adenoid cystic carcinoma of the oral cavity stage IV


subject: CHEBI:32551

object_name: Adenoid cystic carcinoma of the oral cavity stage II


subject: CHEBI:32551

object_name: Adenoid cystic carcinoma of the oral cavity stage I


subject: CHEBI:32551

object_name: Verrucous carcinoma of the oral cavity stage III


subject: CHEBI:32551

object_name: Verrucous carcinoma of the oral cavity stage II


subject: CHEBI:32551

object_name: Verrucous carcinoma of the oral cavity stage IV


subject: CHEBI:32551

object_name: Salivary gland cancer stage I


subject: CHEBI:32551

object_name: Stage I Major Salivary Gland Cancer AJCC v7


subject: CHEBI:32551

object_name: Verrucous carcinoma of the oral cavity stage I


subject: CHEBI:32551

object_name: Stage II Major Salivary Gland Cancer AJCC v7


subject: CHEBI:32551

object_name: Salivary gland cancer stage II


subject: CHEBI:32551

object_name: Salivary gland cancer stage IV


subject: CHEBI:32551

object_name: Stage IV Major Salivary Gland Cancer AJCC v7


subject: CHEBI:32551

object_name: Salivary gland cancer stage III


subject: CHEBI:32551

object_name: Stage III Major Salivary Gland Cancer AJCC v7


subject: CHEBI:32551

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:32551

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:32551

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: CHEBI:32551

object_name: Hypopharyngeal squamous cell carcinoma stage III


subject: CHEBI:32551

object_name: Nasopharyngeal squamous cell carcinoma stage III


subject: CHEBI:32551

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: CHEBI:32551

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: CHEBI:32551

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:32551

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: CHEBI:32551

object_name: Hypopharyngeal squamous cell carcinoma stage II


subject: CHEBI:32551

object_name: Nasopharyngeal squamous cell carcinoma stage II


subject: CHEBI:32551

object_name: Laryngeal squamous cell carcinoma recurrent


subject: CHEBI:32551

object_name: Hypopharyngeal squamous cell carcinoma stage I


subject: CHEBI:32551

object_name: Nasopharyngeal squamous cell carcinoma stage I


subject: CHEBI:32551

object_name: Oropharyngeal squamous cell carcinoma stage II


subject: CHEBI:32551

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: CHEBI:32551

object_name: Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:32551


subject: CHEBI:32551

object_name: Oropharyngeal squamous cell carcinoma stage I


subject: CHEBI:32551

object_name: Laryngeal squamous cell carcinoma stage III


subject: CHEBI:32551

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:32551

object_name: Laryngeal verrucous carcinoma recurrent


subject: CHEBI:32551

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: CHEBI:32551

object_name: Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:32551

object_name: Laryngeal squamous cell carcinoma stage II


subject: CHEBI:32551

object_name: Stage II Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:32551

object_name: Nasopharyngeal lymphoepithelioma stage III


subject: CHEBI:32551

object_name: Laryngeal squamous cell carcinoma stage I


subject: CHEBI:32551

object_name: Stage I Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:32551

object_name: Oropharyngeal lymphoepithelioma stage III


subject: CHEBI:32551

object_name: Nasopharyngeal lymphoepithelioma stage II


subject: CHEBI:32551

object_name: Nasopharyngeal lymphoepithelioma stage IV


subject: CHEBI:32551

object_name: Recurrent Lip Basal Cell Carcinoma


subject: CHEBI:32551

object_name: Nasopharyngeal lymphoepithelioma stage I


subject: CHEBI:32551

object_name: Oropharyngeal lymphoepithelioma stage II


subject: CHEBI:32551

object_name: Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7


subject: CHEBI:32551

object_name: Oropharyngeal lymphoepithelioma stage I


subject: CHEBI:32551

object_name: Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: CHEBI:32551

object_name: Laryngeal verrucous carcinoma stage III


subject: CHEBI:32551

object_name: Laryngeal verrucous carcinoma stage II


subject: CHEBI:32551

object_name: Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: CHEBI:32551

object_name: Laryngeal verrucous carcinoma stage IV


subject: CHEBI:32551

object_name: Laryngeal verrucous carcinoma stage I


subject: CHEBI:32551

object_name: Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: CHEBI:32551

object_name: Stage III Lip Basal Cell Carcinoma


subject: CHEBI:32551

object_name: Stage II Lip Basal Cell Carcinoma


subject: CHEBI:32551

object_name: Stage IV Lip Basal Cell Carcinoma


subject: CHEBI:32551

object_name: Stage I Lip Basal Cell Carcinoma


subject: CHEBI:29967

subject_name: L-lysine residue

object_name: mucositis


subject: CHEBI:29967

object_name: Oral Complication of Radiation Therapy


subject: CHEBI:29967

object_name: Oral Complication of Chemotherapy


subject: CHEBI:29967

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:29967

object_name: Mucoepidermoid carcinoma of the oral cavity recurrent


subject: CHEBI:29967

object_name: Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:29967

object_name: Stage II Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:29967

object_name: Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:29967

object_name: Stage I Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:29967

object_name: Mucoepidermoid carcinoma of the oral cavity stage III


subject: CHEBI:29967

object_name: Mucoepidermoid carcinoma of the oral cavity stage II


subject: CHEBI:29967

object_name: Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


subject: CHEBI:29967

object_name: Mucoepidermoid carcinoma of the oral cavity stage I


subject: CHEBI:29967

object_name: Recurrent Salivary Gland Cancer


subject: CHEBI:29967

object_name: Adenoid cystic carcinoma of the oral cavity recurrent


subject: CHEBI:29967

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: CHEBI:29967

object_name: Adenoid cystic carcinoma of the oral cavity stage III


subject: CHEBI:29967

object_name: Adenoid cystic carcinoma of the oral cavity stage IV


subject: CHEBI:29967

object_name: Adenoid cystic carcinoma of the oral cavity stage II


subject: CHEBI:29967

object_name: Adenoid cystic carcinoma of the oral cavity stage I


subject: CHEBI:29967

object_name: Verrucous carcinoma of the oral cavity stage III


subject: CHEBI:29967

object_name: Verrucous carcinoma of the oral cavity stage II


subject: CHEBI:29967

object_name: Verrucous carcinoma of the oral cavity stage IV


subject: CHEBI:29967

object_name: Salivary gland cancer stage I


subject: CHEBI:29967

object_name: Stage I Major Salivary Gland Cancer AJCC v7


subject: CHEBI:29967

object_name: Verrucous carcinoma of the oral cavity stage I


subject: CHEBI:29967

object_name: Stage II Major Salivary Gland Cancer AJCC v7


subject: CHEBI:29967

object_name: Salivary gland cancer stage II


subject: CHEBI:29967

object_name: Salivary gland cancer stage IV


subject: CHEBI:29967

object_name: Stage IV Major Salivary Gland Cancer AJCC v7


subject: CHEBI:29967

object_name: Salivary gland cancer stage III


subject: CHEBI:29967

object_name: Stage III Major Salivary Gland Cancer AJCC v7


subject: CHEBI:29967

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:29967

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:29967

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: CHEBI:29967

object_name: Hypopharyngeal squamous cell carcinoma stage III


subject: CHEBI:29967

object_name: Nasopharyngeal squamous cell carcinoma stage III


subject: CHEBI:29967

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: CHEBI:29967

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: CHEBI:29967

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:29967

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: CHEBI:29967

object_name: Hypopharyngeal squamous cell carcinoma stage II


subject: CHEBI:29967

object_name: Nasopharyngeal squamous cell carcinoma stage II


subject: CHEBI:29967

object_name: Laryngeal squamous cell carcinoma recurrent


subject: CHEBI:29967

object_name: Hypopharyngeal squamous cell carcinoma stage I


subject: CHEBI:29967

object_name: Nasopharyngeal squamous cell carcinoma stage I


subject: CHEBI:29967

object_name: Oropharyngeal squamous cell carcinoma stage II


subject: CHEBI:29967

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: CHEBI:29967

object_name: Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:29967


subject: CHEBI:29967

object_name: Oropharyngeal squamous cell carcinoma stage I


subject: CHEBI:29967

object_name: Laryngeal squamous cell carcinoma stage III


subject: CHEBI:29967

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:29967

object_name: Laryngeal verrucous carcinoma recurrent


subject: CHEBI:29967

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: CHEBI:29967

object_name: Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:29967

object_name: Laryngeal squamous cell carcinoma stage II


subject: CHEBI:29967

object_name: Stage II Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:29967

object_name: Nasopharyngeal lymphoepithelioma stage III


subject: CHEBI:29967

object_name: Laryngeal squamous cell carcinoma stage I


subject: CHEBI:29967

object_name: Stage I Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:29967

object_name: Oropharyngeal lymphoepithelioma stage III


subject: CHEBI:29967

object_name: Nasopharyngeal lymphoepithelioma stage II


subject: CHEBI:29967

object_name: Nasopharyngeal lymphoepithelioma stage IV


subject: CHEBI:29967

object_name: Recurrent Lip Basal Cell Carcinoma


subject: CHEBI:29967

object_name: Nasopharyngeal lymphoepithelioma stage I


subject: CHEBI:29967

object_name: Oropharyngeal lymphoepithelioma stage II


subject: CHEBI:29967

object_name: Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7


subject: CHEBI:29967

object_name: Oropharyngeal lymphoepithelioma stage I


subject: CHEBI:29967

object_name: Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: CHEBI:29967

object_name: Laryngeal verrucous carcinoma stage III


subject: CHEBI:29967

object_name: Laryngeal verrucous carcinoma stage II


subject: CHEBI:29967

object_name: Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: CHEBI:29967

object_name: Laryngeal verrucous carcinoma stage IV


subject: CHEBI:29967

object_name: Laryngeal verrucous carcinoma stage I


subject: CHEBI:29967

object_name: Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: CHEBI:29967

object_name: Stage III Lip Basal Cell Carcinoma


subject: CHEBI:29967

object_name: Stage II Lip Basal Cell Carcinoma


subject: CHEBI:29967

object_name: Stage IV Lip Basal Cell Carcinoma


subject: CHEBI:29967

object_name: Stage I Lip Basal Cell Carcinoma


subject: CHEBI:133538

subject_name: Lysine

object_name: mucositis


subject: CHEBI:133538

object_name: Oral Complication of Radiation Therapy


subject: CHEBI:133538

object_name: Oral Complication of Chemotherapy


subject: CHEBI:133538

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:133538

object_name: Mucoepidermoid carcinoma of the oral cavity recurrent


subject: CHEBI:133538

object_name: Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:133538

object_name: Stage II Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:133538

object_name: Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:133538

object_name: Stage I Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:133538

object_name: Mucoepidermoid carcinoma of the oral cavity stage III


subject: CHEBI:133538

object_name: Mucoepidermoid carcinoma of the oral cavity stage II


subject: CHEBI:133538

object_name: Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


subject: CHEBI:133538

object_name: Mucoepidermoid carcinoma of the oral cavity stage I


subject: CHEBI:133538

object_name: Recurrent Salivary Gland Cancer


subject: CHEBI:133538

object_name: Adenoid cystic carcinoma of the oral cavity recurrent


subject: CHEBI:133538

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: CHEBI:133538

object_name: Adenoid cystic carcinoma of the oral cavity stage III


subject: CHEBI:133538

object_name: Adenoid cystic carcinoma of the oral cavity stage IV


subject: CHEBI:133538

object_name: Adenoid cystic carcinoma of the oral cavity stage II


subject: CHEBI:133538

object_name: Adenoid cystic carcinoma of the oral cavity stage I


subject: CHEBI:133538

object_name: Verrucous carcinoma of the oral cavity stage III


subject: CHEBI:133538

object_name: Verrucous carcinoma of the oral cavity stage II


subject: CHEBI:133538

object_name: Verrucous carcinoma of the oral cavity stage IV


subject: CHEBI:133538

object_name: Salivary gland cancer stage I


subject: CHEBI:133538

object_name: Stage I Major Salivary Gland Cancer AJCC v7


subject: CHEBI:133538

object_name: Verrucous carcinoma of the oral cavity stage I


subject: CHEBI:133538

object_name: Stage II Major Salivary Gland Cancer AJCC v7


subject: CHEBI:133538

object_name: Salivary gland cancer stage II


subject: CHEBI:133538

object_name: Salivary gland cancer stage IV


subject: CHEBI:133538

object_name: Stage IV Major Salivary Gland Cancer AJCC v7


subject: CHEBI:133538

object_name: Salivary gland cancer stage III


subject: CHEBI:133538

object_name: Stage III Major Salivary Gland Cancer AJCC v7


subject: CHEBI:133538

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:133538

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:133538

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: CHEBI:133538

object_name: Hypopharyngeal squamous cell carcinoma stage III


subject: CHEBI:133538

object_name: Nasopharyngeal squamous cell carcinoma stage III


subject: CHEBI:133538

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: CHEBI:133538

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: CHEBI:133538

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:133538

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: CHEBI:133538

object_name: Hypopharyngeal squamous cell carcinoma stage II


subject: CHEBI:133538

object_name: Nasopharyngeal squamous cell carcinoma stage II


subject: CHEBI:133538

object_name: Laryngeal squamous cell carcinoma recurrent


subject: CHEBI:133538

object_name: Hypopharyngeal squamous cell carcinoma stage I


subject: CHEBI:133538

object_name: Nasopharyngeal squamous cell carcinoma stage I


subject: CHEBI:133538

object_name: Oropharyngeal squamous cell carcinoma stage II


subject: CHEBI:133538

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: CHEBI:133538

object_name: Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:133538


subject: CHEBI:133538

object_name: Oropharyngeal squamous cell carcinoma stage I


subject: CHEBI:133538

object_name: Laryngeal squamous cell carcinoma stage III


subject: CHEBI:133538

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:133538

object_name: Laryngeal verrucous carcinoma recurrent


subject: CHEBI:133538

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: CHEBI:133538

object_name: Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:133538

object_name: Laryngeal squamous cell carcinoma stage II


subject: CHEBI:133538

object_name: Stage II Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:133538

object_name: Nasopharyngeal lymphoepithelioma stage III


subject: CHEBI:133538

object_name: Laryngeal squamous cell carcinoma stage I


subject: CHEBI:133538

object_name: Stage I Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:133538

object_name: Oropharyngeal lymphoepithelioma stage III


subject: CHEBI:133538

object_name: Nasopharyngeal lymphoepithelioma stage II


subject: CHEBI:133538

object_name: Nasopharyngeal lymphoepithelioma stage IV


subject: CHEBI:133538

object_name: Recurrent Lip Basal Cell Carcinoma


subject: CHEBI:133538

object_name: Nasopharyngeal lymphoepithelioma stage I


subject: CHEBI:133538

object_name: Oropharyngeal lymphoepithelioma stage II


subject: CHEBI:133538

object_name: Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7


subject: CHEBI:133538

object_name: Oropharyngeal lymphoepithelioma stage I


subject: CHEBI:133538

object_name: Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: CHEBI:133538

object_name: Laryngeal verrucous carcinoma stage III


subject: CHEBI:133538

object_name: Laryngeal verrucous carcinoma stage II


subject: CHEBI:133538

object_name: Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: CHEBI:133538

object_name: Laryngeal verrucous carcinoma stage IV


subject: CHEBI:133538

object_name: Laryngeal verrucous carcinoma stage I


subject: CHEBI:133538

object_name: Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: CHEBI:133538

object_name: Stage III Lip Basal Cell Carcinoma


subject: CHEBI:133538

object_name: Stage II Lip Basal Cell Carcinoma


subject: CHEBI:133538

object_name: Stage IV Lip Basal Cell Carcinoma


subject: CHEBI:133538

object_name: Stage I Lip Basal Cell Carcinoma


subject: UMLS:C0024337

subject_name: lysine

object_name: mucositis


subject: UMLS:C0024337

object_name: Oral Complication of Radiation Therapy


subject: UMLS:C0024337

object_name: Oral Complication of Chemotherapy


subject: UMLS:C0024337

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: UMLS:C0024337

object_name: Mucoepidermoid carcinoma of the oral cavity recurrent


subject: UMLS:C0024337

object_name: Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UMLS:C0024337

object_name: Stage II Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UMLS:C0024337

object_name: Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UMLS:C0024337

object_name: Stage I Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UMLS:C0024337

object_name: Mucoepidermoid carcinoma of the oral cavity stage III


subject: UMLS:C0024337

object_name: Mucoepidermoid carcinoma of the oral cavity stage II


subject: UMLS:C0024337

object_name: Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


subject: UMLS:C0024337

object_name: Mucoepidermoid carcinoma of the oral cavity stage I


subject: UMLS:C0024337

object_name: Recurrent Salivary Gland Cancer


subject: UMLS:C0024337

object_name: Adenoid cystic carcinoma of the oral cavity recurrent


subject: UMLS:C0024337

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: UMLS:C0024337

object_name: Adenoid cystic carcinoma of the oral cavity stage III


subject: UMLS:C0024337

object_name: Adenoid cystic carcinoma of the oral cavity stage IV


subject: UMLS:C0024337

object_name: Adenoid cystic carcinoma of the oral cavity stage II


subject: UMLS:C0024337

object_name: Adenoid cystic carcinoma of the oral cavity stage I


subject: UMLS:C0024337

object_name: Verrucous carcinoma of the oral cavity stage III


subject: UMLS:C0024337

object_name: Verrucous carcinoma of the oral cavity stage II


subject: UMLS:C0024337

object_name: Verrucous carcinoma of the oral cavity stage IV


subject: UMLS:C0024337

object_name: Salivary gland cancer stage I


subject: UMLS:C0024337

object_name: Stage I Major Salivary Gland Cancer AJCC v7


subject: UMLS:C0024337

object_name: Verrucous carcinoma of the oral cavity stage I


subject: UMLS:C0024337

object_name: Stage II Major Salivary Gland Cancer AJCC v7


subject: UMLS:C0024337

object_name: Salivary gland cancer stage II


subject: UMLS:C0024337

object_name: Salivary gland cancer stage IV


subject: UMLS:C0024337

object_name: Stage IV Major Salivary Gland Cancer AJCC v7


subject: UMLS:C0024337

object_name: Salivary gland cancer stage III


subject: UMLS:C0024337

object_name: Stage III Major Salivary Gland Cancer AJCC v7


subject: UMLS:C0024337

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: UMLS:C0024337

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: UMLS:C0024337

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: UMLS:C0024337

object_name: Hypopharyngeal squamous cell carcinoma stage III


subject: UMLS:C0024337

object_name: Nasopharyngeal squamous cell carcinoma stage III


subject: UMLS:C0024337

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: UMLS:C0024337

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: UMLS:C0024337

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C0024337

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: UMLS:C0024337

object_name: Hypopharyngeal squamous cell carcinoma stage II


subject: UMLS:C0024337

object_name: Nasopharyngeal squamous cell carcinoma stage II


subject: UMLS:C0024337

object_name: Laryngeal squamous cell carcinoma recurrent


subject: UMLS:C0024337

object_name: Hypopharyngeal squamous cell carcinoma stage I


subject: UMLS:C0024337

object_name: Nasopharyngeal squamous cell carcinoma stage I


subject: UMLS:C0024337

object_name: Oropharyngeal squamous cell carcinoma stage II


subject: UMLS:C0024337

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: UMLS:C0024337

object_name: Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C0024337


subject: UMLS:C0024337

object_name: Oropharyngeal squamous cell carcinoma stage I


subject: UMLS:C0024337

object_name: Laryngeal squamous cell carcinoma stage III


subject: UMLS:C0024337

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: UMLS:C0024337

object_name: Laryngeal verrucous carcinoma recurrent


subject: UMLS:C0024337

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: UMLS:C0024337

object_name: Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C0024337

object_name: Laryngeal squamous cell carcinoma stage II


subject: UMLS:C0024337

object_name: Stage II Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: UMLS:C0024337

object_name: Nasopharyngeal lymphoepithelioma stage III


subject: UMLS:C0024337

object_name: Laryngeal squamous cell carcinoma stage I


subject: UMLS:C0024337

object_name: Stage I Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: UMLS:C0024337

object_name: Oropharyngeal lymphoepithelioma stage III


subject: UMLS:C0024337

object_name: Nasopharyngeal lymphoepithelioma stage II


subject: UMLS:C0024337

object_name: Nasopharyngeal lymphoepithelioma stage IV


subject: UMLS:C0024337

object_name: Recurrent Lip Basal Cell Carcinoma


subject: UMLS:C0024337

object_name: Nasopharyngeal lymphoepithelioma stage I


subject: UMLS:C0024337

object_name: Oropharyngeal lymphoepithelioma stage II


subject: UMLS:C0024337

object_name: Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7


subject: UMLS:C0024337

object_name: Oropharyngeal lymphoepithelioma stage I


subject: UMLS:C0024337

object_name: Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: UMLS:C0024337

object_name: Laryngeal verrucous carcinoma stage III


subject: UMLS:C0024337

object_name: Laryngeal verrucous carcinoma stage II


subject: UMLS:C0024337

object_name: Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: UMLS:C0024337

object_name: Laryngeal verrucous carcinoma stage IV


subject: UMLS:C0024337

object_name: Laryngeal verrucous carcinoma stage I


subject: UMLS:C0024337

object_name: Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: UMLS:C0024337

object_name: Stage III Lip Basal Cell Carcinoma


subject: UMLS:C0024337

object_name: Stage II Lip Basal Cell Carcinoma


subject: UMLS:C0024337

object_name: Stage IV Lip Basal Cell Carcinoma


subject: UMLS:C0024337

object_name: Stage I Lip Basal Cell Carcinoma


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: lung cancer


subject: PUBCHEM.COMPOUND:1805

object_name: lung neoplasm


subject: PUBCHEM.COMPOUND:1805

object_name: lung carcinoma


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:49140

object_name: abdominal aortic aneurysm


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)


subject: CHEBI:36560

subject_name: Zinc oxide

object_name: Pressure injury of buttock


subject: CHEBI:36560

object_name: decubitus ulcer


subject: CHEBI:36560

object_name: Crushing injury


subject: CHEBI:36560

object_name: Pressure injury stage II


subject: UNII:DTI67O9503

subject_name: Alglucosidase alfa

object_name: glycogen storage disease due to acid maltase deficiency, infantile onset


subject: UNII:DTI67O9503

object_name: Acid Maltase Deficiency


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: Evidence of liver transplantation


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:31409

object_name: Dravet syndrome


subject: CHEBI:31409

object_name: developmental and epileptic encephalopathy, 6A


subject: UMLS:C0772142

subject_name: clemizole HCl


subject: UMLS:C0772142


subject: UNII:G2D52T65LR

subject_name: Coleneuramide

object_name: diabetic polyneuropathy


subject: CHEBI:28911

subject_name: cob(III)alamin

object_name: Vitamin B12 absorption


subject: PUBCHEM.COMPOUND:165339223

subject_name: Vitamin B 12


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: CHEBI:176843

subject_name: vitamin B12


subject: UMLS:C0086024

subject_name: cobalamins


subject: CHEBI:17439


subject: UMLS:C2936883

subject_name: Vitamin B12 [EPC]


subject: UNII:P6YC3EG204

subject_name: Erythrotin


subject: CHEBI:15982

subject_name: cob(I)alamin


subject: UMLS:C3714801

subject_name: Cyanocobalamin Drug Class


subject: CHEBI:231678

subject_name: Evofosfamide

object_name: plasma cell myeloma


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: chronic childhood arthritis


subject: CHEBI:64321

subject_name: Fosaprepitant


subject: CHEBI:28741

subject_name: Sodium fluoride

object_name: Tooth Discoloration, CTCAE


subject: CHEBI:28741

object_name: Tooth Discoloration


subject: CHEBI:6149

subject_name: Levobupivacaine

object_name: osteoarthritis


subject: CHEBI:6801

subject_name: Metformin

object_name: endogenous depression


subject: CHEBI:6801

object_name: major depressive disorder


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: prostate neoplasm


subject: UMLS:C0879636

subject_name: IMC C225


subject: CHEBI:136034

subject_name: Afamelanotide

object_name: Ischemic stroke


subject: UMLS:C0066889

subject_name: MT-I


subject: CHEBI:95060

subject_name: Dinaciclib

object_name: Plasma cell myeloma refractory


subject: UNII:8ZHS5657EH

subject_name: Tagraxofusp

object_name: adult acute myeloid leukemia


subject: UMLS:C1831974


subject: PUBCHEM.COMPOUND:108142

object_name: colorectal cancer


subject: PUBCHEM.COMPOUND:108142

object_name: colorectal carcinoma


subject: PUBCHEM.COMPOUND:108142

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:BHB013S3MO

subject_name: SARCNU


subject: UNII:BHB013S3MO


subject: UNII:BHB013S3MO


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Hand Injuries and Disorders


subject: CHEBI:6456

object_name: Forearm Injuries


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: extraskeletal Ewing sarcoma


subject: UMLS:C3658854


subject: UMLS:C3491332

object_name: psoriasis


subject: UNII:9603LN7R2Q

subject_name: Creatine Monohydrate

object_name: concussion


subject: UNII:9603LN7R2Q

object_name: Mild Traumatic Brain Injury


subject: CHEBI:16919

subject_name: Creatine


subject: CHEBI:5558

subject_name: Guanfacine

object_name: cannabis abuse


subject: UMLS:C0244111

subject_name: alpha-conotoxin GI

object_name: type 2 diabetes mellitus


subject: CHEBI:93851

subject_name: Celestone

object_name: Back Pain, CTCAE 5.0


subject: CHEBI:93851

object_name: Back pain


subject: CHEBI:93851

object_name: Back Pain, CTCAE 3.0


subject: CHEBI:93851

object_name: Neck pain


subject: CHEBI:93851

object_name: Neck Pain, CTCAE 5.0


subject: CHEBI:93851

object_name: Neck Pain, CTCAE 3.0


subject: UMLS:C0701247


subject: UMLS:C0701247


subject: UMLS:C0701247


subject: UMLS:C0701247


subject: UMLS:C0701247


subject: UMLS:C0701247


subject: UMLS:C4722471

object_name: age-related macular degeneration


subject: UNII:XSZ53G39H5

subject_name: Brolucizumab

object_name: Wet age-related macular degeneration


subject: CHEBI:28911

subject_name: cob(III)alamin

object_name: Human Papilloma Virus, Female


subject: CHEBI:28911

object_name: Human Papilloma Virus, Male


subject: PUBCHEM.COMPOUND:165339223

subject_name: Vitamin B 12


subject: PUBCHEM.COMPOUND:165339223


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: HMDB:HMDB0000607


subject: CHEBI:176843

subject_name: vitamin B12


subject: CHEBI:176843


subject: UMLS:C0086024

subject_name: cobalamins


subject: UMLS:C0086024


subject: CHEBI:17439


subject: CHEBI:17439


subject: UMLS:C2936883

subject_name: Vitamin B12 [EPC]


subject: UMLS:C2936883


subject: PUBCHEM.COMPOUND:135405876

subject_name: Folate


subject: PUBCHEM.COMPOUND:135405876


subject: CHEBI:62501


subject: CHEBI:62501


subject: CHEBI:37445

subject_name: folic acids


subject: CHEBI:37445


subject: UMLS:C0178638

subject_name: folate


subject: UMLS:C0178638


subject: CHEBI:67011

subject_name: folates


subject: CHEBI:67011


subject: CHEBI:27470

subject_name: Folic acid


subject: CHEBI:27470


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: Finger Injuries


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Platelet dysfunction


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: CHEBI:6801

subject_name: Metformin

object_name: neoplasm of thorax


subject: CHEBI:51141

subject_name: Alfuzosin

object_name: Benign prostatic hyperplasia with outflow obstruction


subject: UNII:3A58010674

subject_name: Pegfilgrastim

object_name: Neoplasm of uncertain or unknown behavior of breast


subject: UNII:3A58010674

object_name: Breast problem


subject: CHEBI:49960

subject_name: Vandetanib

object_name: invasive breast carcinoma


subject: UNII:43K1W2T1M6

subject_name: Interferon alfa-2b

object_name: hepatitis A


subject: UNII:43K1W2T1M6

object_name: hepatitis


subject: UMLS:C0021735

subject_name: Viraferon


subject: UMLS:C0021735